NELSON MULLINS RILEY & SCARBOROUGH

Lobbying for ANBEX, INC. · Pharmaceutical Manufacturing

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Maryland · House · Senate · $15,000.00 income · posted Jan 9, 2026

Lobbying activity 2

Medical/Disease Research/Clinical Labs

Stockpile potassium iodide to counteract effects of nuclear radiation.

Energy/Nuclear

The utilization of potassium iodide to protect against nuclear radiation.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.